TUESDAY, July 20, 2021 (HealthDay Information) — Might cholesterol-lowering statins assist decrease your danger of dying from COVID-19?

For sufferers with a historical past of high blood pressure or heart disease, the reply seems to be sure. At the least that is the conclusion of a brand new research that enlisted roughly 10,500 sufferers throughout 104 U.S. hospitals between January and September of 2020.

All had been admitted with a severe bout of COVID-19. Previous to hospitalization, 42% had been taking statins to rein in high cholesterol, with 7% taking statins alone and 35% taking each statins and blood pressure medications.

In the long run, a couple of fifth of the sufferers both succumbed to COVID-19 or have been discharged to a hospice setting.

“[But] we discovered that sufferers taking statin drugs previous to getting hospitalized because of COVID-19 had a 41% decrease danger of dying throughout that hospitalization, even after adjusting for different elements like age, gender, different medical issues, and what kind of medical insurance coverage that they had,” mentioned research creator Dr. Lori Daniels.

After analyzing information amassed by the American Coronary heart Affiliation, the group additionally concluded that statin use was equally linked to a 25% decrease danger for growing a “extreme consequence” because of COVID-19 an infection.

Why? Statins may need this impact by “stabilizing the underlying coronary heart situations for which they’re prescribed, making sufferers extra more likely to recuperate from COVID-19,” mentioned Daniels, director of the cardiovascular intensive care unit on the College of California, San Diego.

However not all sufferers on statins have superior coronary heart illness, Daniels’ group famous. Many comparatively wholesome sufferers additionally take them in proactively to stave off cardiovascular hassle.

Which begs the query, might statins additionally decrease loss of life amongst COVID sufferers who do not but have severe underlying heart points? Daniels instructed the jury continues to be out on that query.

She famous that statins pack a doubtlessly useful anti-inflammatory punch. Her group discovered that statins drove loss of life danger down by 16% amongst sufferers with no prior historical past of coronary heart illness.

Nonetheless, Daniels cautioned that for coronary heart wholesome sufferers, the trial outcomes have been “not statistically important.” And “the current research can not inform us whether or not giving sufferers statins, if they aren’t already on them, could be useful,” she confused.